Larimar Therapeutics Inc (LRMR)
R&D Expenses
$157.34M
TTM · Period ending: · USD
LRMR R&D Expenses
Latest reported$157.34Mperiod ending
Latest reported$157.34Mperiod ending
LRMR R&D Expenses ($11.40M → $157.34M)
Annual R&D Expenses
High-resolution chart · PNG
LRMR r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 154,224,000 | |
| 73,278,000 | |
| 27,670,000 | |
| 24,250,000 | |
| 38,396,000 | |
| 31,252,000 | |
| 20,790,000 | |
| 49,529,000 | |
| 41,739,000 | |
| 39,774,000 | |
| 54,618,000 | |
| 27,391,000 | |
| 9,561,000 | |
| 11,544,000 | |
| 11,403,000 |